Edge Rewrite
// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a4575ca13b143014

Jump to content

Peter Choong

From Wikipedia, the free encyclopedia

Peter Choong
Born
Peter Fook Meng Choong

Kuala Lumpur, Malaysia
EducationUniversity of Melbourne (MBBS, MD)
OccupationsOrthopaedic surgeon and academic

Peter Fook Meng Choong AO is an Australian orthopaedic surgeon and academic whose clinical and research work concerns musculoskeletal tumours, joint replacement and biofabrication. The University of Melbourne lists him as an honorary enterprise professor in the Melbourne Medical School.[1] He previously served as director of orthopaedics at St Vincent's Hospital, Melbourne from 1996 to 2020, held the Sir Hugh Devine Chair of Surgery, and was president of the Australian Orthopaedic Association in 2013–2014.[2][3]

In 2014, Choong led the St Vincent's surgical team that implanted a custom 3D-printed titanium heel in a patient with cancer, an operation reported as a world first.[4][5] He was appointed an Officer of the Order of Australia in 2022 for service to orthopaedic medicine, research, medical education and professional associations.[6]

Early life and education

[edit]

Choong was born in Kuala Lumpur, Malaysia.[5] He was eight years old during the May 13 riots in Kuala Lumpur in 1969. His family later emigrated to Australia and settled in Noble Park, and he attended Melbourne Grammar School.[7]

Choong studied medicine at the University of Melbourne, graduating in 1984, and completed advanced surgical training at St Vincent's Hospital. After completing an MD, he undertook orthopaedic oncology fellowships at Lund University Hospital in Sweden and the Mayo Clinic in Rochester, Minnesota.[8]

Career

[edit]

In 1996, Choong became director of orthopaedics at St Vincent's Hospital and established a sarcoma service at the Peter MacCallum Cancer Centre.[8] He later chaired Peter MacCallum's Bone and Soft Tissue Sarcoma Service.[9] He was program director of surgery and surgical services at St Vincent's from 1997 to 2002 and chief medical officer from 2005 to 2008.[2] In 2009, the University of Melbourne and St Vincent's appointed him to the Sir Hugh Devine Chair of Surgery.[8]

Choong served on committees and boards of the Australian Orthopaedic Association and was its president from 2013 to 2014. He also chaired the association's Federal Training Committee and the Royal Australasian College of Surgeons' Board of Orthopaedics.[3] He concluded his tenure as director of orthopaedics at St Vincent's in 2020. That year he was appointed head of the Department of Surgery within the Melbourne Medical School.[2] In August 2022, the university appointed him associate dean for innovation and enterprise in its Faculty of Medicine, Dentistry and Health Sciences.[10] The university now lists him as an honorary enterprise professor.[1]

Research

[edit]

Joint replacement and musculoskeletal oncology

[edit]

Choong's research has covered musculoskeletal tumours, joint replacement and advanced limb reconstruction.[3] At St Vincent's he founded the St Vincent's Melbourne Arthroplasty Outcomes Registry in 1998. The registry has been used to study how patient, prosthetic and treatment factors affect outcomes and implant survival.[11] In 2016, he became principal investigator of the NHMRC-funded Centre for Research Excellence in Total Joint Replacement, known as OPUS, which examined patient safety, outcomes, efficiency and equitable access to joint replacement.[12]

His joint-replacement research has included a prospective randomised trial comparing conventional and computer-assisted total knee arthroplasty,[13] studies of infection risk following hip and knee replacement,[14][15] and an international consensus project on outcome domains for joint-replacement trials.[16]

In musculoskeletal oncology, he has co-authored reviews of the treatment and molecular biology of osteosarcoma.[17][18] His clinical research has included a cohort study examining the effect of residual disease after unplanned excision of soft-tissue sarcoma.[19] He edited the 2020 Springer reference work Sarcoma: A Practical Guide to Multidisciplinary Management and contributed chapters on biopsy, surgical margins and limb and pelvic sarcoma surgery.[9]

Biofabrication and medical devices

[edit]

Choong collaborated with materials scientist Gordon Wallace and other researchers on the BioPen, a handheld device designed to deposit cell-containing material at a cartilage wound site. The team published its proof-of-concept work in Biofabrication in 2016,[20] followed by an animal study of handheld bioprinting for cartilage repair.[21] The project was also covered by ABC News during preclinical testing.[22]

Choong was involved in establishing BioFab3D, an advanced biofabrication centre opened at St Vincent's in 2016 to bring clinicians together with researchers in biology, materials science, biomedical engineering and robotics.[23][2] The BioPen team was selected as a finalist in the Australian Museum Eureka Prizes in both 2017 and 2018.[24][25]

The 2014 titanium heel implant involved Choong's surgical team, the Commonwealth Scientific and Industrial Research Organisation and medical-device company Anatomics. A model derived from the patient's other heel was used to produce the implant after cancer affected the calcaneus.[4][5] Choong and Jungo Imanishi subsequently published a case report describing the implant and the patient's early recovery.[26]

In 2017, Choong joined the five-year Just in Time Implants collaboration between RMIT University, the University of Technology Sydney, St Vincent's Hospital, Stryker and the Innovative Manufacturing Cooperative Research Centre. The project investigated combining patient-specific additive manufacturing with robot-assisted bone-tumour surgery.[27] In 2023, the group reported an animal study evaluating robotic tumour excision followed by placement of patient-specific implants.[28]

In 2022, Choong became lead investigator of ARISTOCRAT, a Medical Research Future Fund project on cartilage regeneration and tissue-engineered treatments that received approximately A$7 million.[29] In 2025, he led a further A$7 million MRFF project intended to expand the Australian Spine Registry into a national clinical quality registry for monitoring spinal implants and treatments.[30]

Honours

[edit]
  • In 2008, Choong received the John Mitchell Crouch Fellowship from the Royal Australasian College of Surgeons.[3]
  • The Mayo Clinic appointed him Ivins Visiting Professor in 2003 and Coventry Visiting Professor in 2014.[3]
  • He was elected a fellow of the Australian Academy of Health and Medical Sciences in 2015.[3]
  • The Australian Orthopaedic Association gave him its Award for Service to Orthopaedic Research in 2015.[31]
  • In 2019, the National Health and Medical Research Council awarded Choong its highest-ranked Practitioner Fellowship for research on the care of end-stage osteoarthritis.[32]
  • He was appointed an Officer of the Order of Australia in the 2022 Queen's Birthday Honours.[6]

References

[edit]
  1. 1 2 "Prof Peter Choong". Find an Expert. University of Melbourne. Retrieved 27 August 2026.
  2. 1 2 3 4 "Queen's Birthday Honours 2022". St Vincent's Hospital Melbourne. 12 June 2022. Retrieved 27 August 2026.
  3. 1 2 3 4 5 6 "Professor Peter Choong". Australian Academy of Health and Medical Sciences. 11 October 2015. Retrieved 27 August 2026.
  4. 1 2 Tucker, Lisa (21 October 2014). "3D printing: Rare cancer sufferer, Len Chandler, back on his feet after receiving titanium printed heel". ABC News. Retrieved 27 August 2026.
  5. 1 2 3 "Malaysian-born surgeon puts patient back on feet with world's first 3D-printed heel transplant". Malay Mail. Bernama. 21 October 2014. Retrieved 27 August 2026.
  6. 1 2 "Professor Peter Fook Meng Choong". Australian Honours Search Facility. Department of the Prime Minister and Cabinet. 12 June 2022. Retrieved 27 August 2026.
  7. ↑ "Focusing on the future". AMES Australia. Retrieved 27 August 2026.
  8. 1 2 3 "Prominent cancer surgeon takes role as new Hugh Devine Chair of Surgery". University of Melbourne. 6 October 2009. Archived from the original on 5 August 2010. Retrieved 27 August 2026.
  9. 1 2 Choong, Peter F. M., ed. (2020). Sarcoma: A Practical Guide to Multidisciplinary Management. Springer Singapore. doi:10.1007/978-981-15-9414-4. ISBN 978-981-15-9414-4.
  10. ↑ "Professor Peter Choong AO appointed MDHS Associate Dean Innovation and Enterprise". University of Melbourne. 13 July 2022. Retrieved 27 August 2026.
  11. ↑ "AOA Member Research showcase". Australian Orthopaedic Association. Retrieved 27 August 2026.
  12. ↑ "Centre for Research Excellence in Total Joint Replacement OPtimising oUtcomes, equity, cost effectiveness and patient Selection (OPUS)". Australian Research Data Commons. Retrieved 27 August 2026.
  13. ↑ Choong, Peter F.; Dowsey, Michelle M.; Stoney, James D. (June 2009). "Does accurate anatomical alignment result in better function and quality of life? Comparing conventional and computer-assisted total knee arthroplasty". The Journal of Arthroplasty. 24 (4): 560–569. doi:10.1016/j.arth.2008.02.018. PMID 18534397.
  14. ↑ Dowsey, Michelle M.; Choong, Peter F. M. (January 2008). "Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty". Clinical Orthopaedics and Related Research. 466 (1): 153–158. doi:10.1007/s11999-007-0016-3. PMC 2505299. PMID 18196388.
  15. ↑ Dowsey, Michelle M.; Choong, Peter F. M. (June 2009). "Obese diabetic patients are at substantial risk for deep infection after primary TKA". Clinical Orthopaedics and Related Research. 467 (6): 1577–1581. doi:10.1007/s11999-008-0551-6. PMC 2674158. PMID 18841430.
  16. ↑ Singh, Jasvinder A.; Dohm, Michael; Choong, Peter F. (January 2017). "Consensus on draft OMERACT core domains for clinical trials of total joint replacement outcome by orthopaedic surgeons: a report from the International consensus on outcome measures in TJR trials (I-COMiTT) group". BMC Musculoskeletal Disorders. 18 (1) 45. doi:10.1186/s12891-017-1409-4. PMC 5260035. PMID 28122568.
  17. ↑ Ta, Hang T.; Dass, Crispin R.; Choong, Peter F. M.; Dunstan, Dave E. (June 2009). "Osteosarcoma treatment: state of the art". Cancer and Metastasis Reviews. 28 (1–2): 247–263. doi:10.1007/s10555-009-9186-7. PMID 19214708.
  18. ↑ Broadhead, Matthew L.; Clark, Jonathan C. M.; Myers, Damian E.; Dass, Crispin R.; Choong, Peter F. M. (2011). "The molecular pathogenesis of osteosarcoma: a review". Sarcoma: 1–12. doi:10.1155/2011/959248. PMC 3087974. PMID 21559211.
  19. ↑ Charoenlap, Chris; Imanishi, Jungo; Tanaka, Takaaki; Slavin, John; Ngan, Samuel Y.; Chander, Sarat; Dowsey, Michelle M.; Goyal, Chatar; Choong, Peter F. M. (June 2016). "Outcomes of unplanned sarcoma excision: impact of residual disease". Cancer Medicine. 5 (6): 980–988. doi:10.1002/cam4.615. PMC 4924354. PMID 26929181.
  20. ↑ O'Connell, Cathal D.; Di Bella, Claudia; Thompson, Fletcher; Augustine, Cheryl; Beirne, Stephen; Cornock, Rhys; Richards, Christopher J.; Chung, Johnson; Gambhir, Sanjeev; Yue, Zhilian; Bourke, Justin; Zhang, Binbin; Taylor, Adam; Quigley, Anita; Kapsa, Robert; Choong, Peter; Wallace, Gordon G. (March 2016). "Development of the Biopen: a handheld device for surgical printing of adipose stem cells at a chondral wound site". Biofabrication. 8 (1) 015019. Bibcode:2016BioFa...8a5019O. doi:10.1088/1758-5090/8/1/015019. PMID 27004561.
  21. ↑ Di Bella, Claudia; Duchi, Serena; O'Connell, Cathal D.; Blanchard, Romane; Augustine, Cheryl; Yue, Zhilian; Thompson, Fletcher; Richards, Christopher; Beirne, Stephen; Onofrillo, Carmine; Bauquier, Sébastien H.; Ryan, Stephen D.; Pivonka, Peter; Wallace, Gordon G.; Choong, Peter F. (March 2018). "In situ handheld three-dimensional bioprinting for cartilage regeneration". Journal of Tissue Engineering and Regenerative Medicine. 12 (3): 611–621. doi:10.1002/term.2476. PMID 28512850.
  22. ↑ "3D cell printer tipped to be 'game changer' in preventing osteoarthritis". ABC News. 25 May 2017. Retrieved 27 August 2026.
  23. ↑ "Advanced Biofabrication Centre launched at St Vincent's Hospital". University of Melbourne. 13 October 2016. Retrieved 27 August 2026.
  24. ↑ Campbell, Kate (28 July 2017). "Award nod for handheld 3D device which will repair cartilage". Illawarra Mercury. Retrieved 27 August 2026.
  25. ↑ "ACES teams named as 2018 Eureka Prizes finalists". ARC Centre of Excellence for Electromaterials Science. 25 July 2018. Retrieved 27 August 2026.
  26. ↑ Imanishi, Jungo; Choong, Peter F. M. (2015). "Three-dimensional printed calcaneal prosthesis following total calcanectomy". International Journal of Surgery Case Reports. 10: 83–87. doi:10.1016/j.ijscr.2015.02.037. PMC 4429954. PMID 25827294.
  27. ↑ "Just-in-time 3-D implants set to transform tumor surgery". Medical Xpress. RMIT University. 30 October 2017. Retrieved 27 August 2026.
  28. ↑ Williamson, Tom; Ryan, Stewart; Buehner, Ulrich; Sweeney, Zac; Hill, Dave; Lozanovski, Bill; Kastrati, Endri; Namvar, Arman; Beths, Thierry; Shidid, Darpan; Blanchard, Romane; Fox, Kate; Leary, Martin; Choong, Peter; Brandt, Milan (October 2023). "Robot-assisted implantation of additively manufactured patient-specific orthopaedic implants: evaluation in a sheep model". International Journal of Computer Assisted Radiology and Surgery. 18 (10): 1783–1793. doi:10.1007/s11548-023-02848-8. PMC 10497442. PMID 36859520.
  29. ↑ "Stem cell research to enable cartilage regeneration receives major funding boost". St Vincent's Hospital Melbourne. 29 September 2022. Retrieved 27 August 2026.
  30. ↑ "ASPIRE awarded MRFF grant". University of Melbourne. 4 April 2025. Retrieved 27 August 2026.
  31. ↑ "Honours and awards". Australian Orthopaedic Association. Retrieved 27 August 2026.
  32. ↑ Annual Report 2018–19 (PDF) (Report). National Health and Medical Research Council. 2019. p. 29. Retrieved 27 August 2026.
[edit]